Craniomaxillofacial Devices Market Size By Product (MF Plate and Screw Fixation System, Cranial Flap Fixation System, CMF Distraction System, Temporomandibular Joint Replacement System, Thoracic Fixation System, Bone Graft Substitute System), By Implant T

Craniomaxillofacial Devices Market Size By Product (MF Plate and Screw Fixation System, Cranial Flap Fixation System, CMF Distraction System, Temporomandibular Joint Replacement System, Thoracic Fixation System, Bone Graft Substitute System), By Implant Type (Standard Implants, Customized/Patient-specific Implants), By Location (Internal Fixators, External Fixators), By Materials (Metals, Bioabsorbable Materials, Ceramics, Polymers), By Application (Trauma Reconstruction Surgery {Cranial Surgery, Mid-face Surgery, Mandibular Surgery, Orbital Floor Reconstruction Surgery}, Orthognathic Surgery, Plastic Surgery), By Resorbability (Resorbable Fixators, Non- Resorbable Fixators), By Device Type (Reconstruction Surgery Devices, Trauma Surgery Devices), By End-use (Hospitals, Ambulatory Surgery Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2030

The craniomaxillofacial devices market is set to witness massive growth by 2030 owing to rising occurrences of traffic accidents and facial injuries. Additionally, high consumer inclination toward minimally invasive surgical procedures is also expected to drive market growth over the forecast timespan.

Recently, surging emphasis on research & development and innovation in the field has been beneficial for the product landscape, thereby improving overall market dynamics. For instance, in March 2022, Zimmer Biomet, a medical device company, launched its first AI-based software, the WalkAI tool, which can predict of patients’ recovery after knee or hip surgery.

The craniomaxillofacial devices market has been bifurcated on the basis of implant type, resorbability, end-use, application, location, product, material, device type, and region.

With regard to end-use, the market has been divided into ambulatory surgery centers, hospitals, and others. Among these, the hospitals segment accounted for a majority revenue share of more than 60% in the market in 2021 as a result of rising cases of craniofacial fractures and high patient preference for receiving treatment at hospitals.

Based on device type, the craniomaxillofacial devices market has been segmented into trauma surgery devices and reconstruction surgery devices. The trauma surgery devices segment was valued at over $439.1 million in 2021 on account of increasing prevalence of traumatic accidents that boosts the incidences of maxillofacial injuries.

By product, the market has been segregated into CMF distraction system, bone graft substitute system, MF plate and screw fixation system, temporomandibular joint replacement system, cranial flap fixation system, and thoracic fixation system. The thoracic fixation system segment is speculated to grow at a rate of approximately 8.3% between 2022 and 2030 primarily attributed to technological advancements and novel product launches by prominent players worldwide.

The craniomaxillofacial devices market has been categorized in terms of resorbability into non-resorbable fixators and resorbable fixators. The resorbable fixators segment is anticipated to exhibit significant growth to reach a valuation of around $975 million by 2030 as a result of increased spending by key producers on R&D activities associated with resorbable rigid fixation systems, which are gaining popularity in the treatment of facial trauma.

In the context of implant type, the industry has been classified into customized/patient-specific implants and standard implants. The customized/patient-specific implants segment is estimated to exceed $1,076 million in revenue by 2030 due to soaring preference for customized implants in craniomaxillofacial surgeries, notable advancements in manufacturing technology, and clinical advantages.

With respect to application, the market has been segmented into plastic surgery, trauma reconstruction surgery, and orthognathic surgery. In 2021, the plastic surgery segment surpassed a valuation of $298 million driven by escalating demand and number of plastic surgeries that involve craniomaxillofacial implants.

On the basis of material, the craniomaxillofacial devices market has been split into ceramics, metals, polymers, and bioabsorbable materials. The polymers segment accounted for a substantial market share in 2021 and is set to expand at nearly 9.3% CAGR over 2022-2030 propelled by the benefits offered by polymers as a CMF implant manufacturing material.

From location perspective, the market has been segregated into external fixators and internal fixators. The internal fixators segment is poised to expand at a rate of above 8.9% from 2022 to 2030. Prevalent use of internal fixation techniques by surgeons to minimize operative complications by reducing soft-tissue disruptions is likely to stimulate segmental progress.

On the regional front, the craniomaxillofacial devices market in the Middle East & Africa region was valued at roughly $45 million in 2021 and is projected to witness robust growth through the forecast period. Escalating incidences of facial fractures and injuries across the countries in the region are foreseen to support MEA industry expansion.